<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="60970">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02312206</url>
  </required_header>
  <id_info>
    <org_study_id>NEOD001-CL002</org_study_id>
    <nct_id>NCT02312206</nct_id>
  </id_info>
  <brief_title>The VITAL Amyloidosis Study, a Global Phase 3, Efficacy and Safety Study of NEOD001 in Patients With AL Amyloidosis</brief_title>
  <acronym>VITAL</acronym>
  <official_title>A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled, 2-Arm, Efficacy and Safety Study of NEOD001 Plus Standard of Care Versus Placebo Plus Standard of Care in Subjects With Light Chain (AL) Amyloidosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Prothena Therapeutics Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Prothena Therapeutics Ltd.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multi-center, international, randomized, double-blind, placebo-controlled, two-arm
      efficacy and safety study in subjects newly diagnosed with AL amyloidosis. Subjects will
      remain on-study until study completion, which will occur when all primary endpoint events
      (all-cause mortality or cardiac hospitalizations) have been reached.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multi-center, international, randomized, double-blind, placebo-controlled, two-arm
      efficacy and safety study in subjects newly diagnosed with AL amyloidosis. Approximately 236
      subjects will be enrolled in ~60 centers, with approximately 118 subjects per arm.

      This is an event driven trial, therefore subjects will remain on-study until study
      completion, which will occur when all primary endpoint events (all-cause mortality or
      cardiac hospitalizations) have been reached. All subjects who discontinue will be followed
      until the last event is adjudicated. The estimated overall study duration is approximately
      42 months, including the enrollment and treatment periods

      Study drug will be administered once every 28 days as a 60-120 minute IV infusion.

      First-line chemotherapy must be a proteasome inhibitor-containing regimen, with the
      proteasome inhibitor administered weekly. The number of cycles of first-line chemotherapy
      that are administered are at the discretion of the Investigator, and subsequent chemotherapy
      regimens may be prescribed as per standard of care at the Investigator's discretion.

      An independent Data Monitoring Committee (DMC) will review data on a regular basis.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to composite of all-cause mortality or cardiac hospitalization</measure>
    <time_frame>From date of randomization until the date of death or cardiac hospitalization, whichever came first, assessed for up to approximately 42 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>NT-proBNP best response</measure>
    <time_frame>Baseline to Month 9</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to cardiac mortality or cardiac hospitalization</measure>
    <time_frame>Baseline to Month 9</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the 6 Minute Walk Test</measure>
    <time_frame>Baseline to Month 9</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the Short Form-36 Questionnaire</measure>
    <time_frame>Baseline to Month 9</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the Kansas City Cardiomyopathy Questionnaire</measure>
    <time_frame>Baseline to Month 9</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renal best response</measure>
    <time_frame>Baseline to Month 9</time_frame>
    <description>As assessed using Palladini et al, 2014 criteria</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hepatic best response assessed using Comenzo et al, 2012 criteria</measure>
    <time_frame>Baseline to Month 9</time_frame>
    <description>As assessed using Comenzo et al, 2012 criteria</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">236</enrollment>
  <condition>Primary Systemic (AL) Amyloidosis</condition>
  <arm_group>
    <arm_group_label>NEOD001</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>24 mg/kg (maximum dose of 2500 mg) of NEOD001 administered once every 28 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo will be administered as a 250 mL bag of normal saline once every 28 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>NEOD001</intervention_name>
    <description>NEOD001, is a humanized immunoglobulin G1 monoclonal antibody, which specifically targets misfolded light chain aggregates and amyloid deposits. NEOD001 is proposed for use to target the misfolded light chain protein in subjects with AL amyloidosis.</description>
    <arm_group_label>NEOD001</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Key Inclusion Criteria:

          1. Age ≥ 18 years

          2. Newly diagnosed, AL amyloidosis treatment naïve

          3. Bone marrow consistent with plasma cell dyscrasia

          4. Confirmed diagnosis of AL amyloidosis

          5. Cardiac involvement

          6. Planned first-line chemotherapy contains a proteasome-inhibiting agent administered
             weekly

          7. Adequate bone marrow reserve, hepatic and renal function

        Key Exclusion Criteria:

          1. Non-AL amyloidosis

          2. Meets diagnostic criteria for symptomatic multiple myeloma

          3. Subject is eligible for and plans to undergo ASCT

          4. History of Grade ≥ 3 infusion-associated AEs or hypersensitivity to another
             monoclonal antibody, or known hypersensitivity to diphenhydramine or acetaminophen
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Deb Chapman</last_name>
    <email>Clinicaltrials@prothena.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Mayo Clinic Arizona</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85259</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office</last_name>
      <phone>855-776-0015</phone>
    </contact>
    <investigator>
      <last_name>Craig Reeder, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>City of Hope</name>
      <address>
        <city>Duarte</city>
        <state>California</state>
        <zip>91010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lupe Duarte</last_name>
      <phone>626-256-4673</phone>
      <phone_ext>63968</phone_ext>
      <email>lduarte@coh.org</email>
    </contact>
    <investigator>
      <last_name>Michael Rosenzweig, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford Cancer Institute (SCI)</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Uzma Ahmed</last_name>
      <phone>650-723-0670</phone>
      <email>uzma.ahmed@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>Michaela Liedtke, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Colorado Blood Cancer Institute</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80218</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeffrey Matous, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jeffrey Matous, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office</last_name>
      <phone>855-776-0015</phone>
    </contact>
    <investigator>
      <last_name>Taimur Sher, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sylvester Cancer Center, University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33312</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nathalie Luis</last_name>
      <phone>305-243-7648</phone>
      <email>nluis@med.miami.edu</email>
    </contact>
    <investigator>
      <last_name>James Hoffman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Winship Cancer Institute of Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jonathan Kaufman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Radiant Research Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie Barath</last_name>
      <email>stephanie.barath@northwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Seema Singhal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Chicago Medicine</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathryn McDonnell</last_name>
      <phone>773-702-1835</phone>
      <email>kmcdonnell@medicine.bsd.uchicago.edu</email>
    </contact>
    <investigator>
      <last_name>Cara Rosenbaum, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Indiana University Cancer Center</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea Bradley</last_name>
      <phone>317-278-4840</phone>
      <email>andbradl@indiana.edu</email>
    </contact>
    <investigator>
      <last_name>Rafat Abonour, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ochsner Clinic Foundation</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert VB Emmons, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>John Hopkins University School of Medicine</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janet Briel</last_name>
      <phone>410-614-0675</phone>
    </contact>
    <investigator>
      <last_name>Carol Ann Huff</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tufts Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>George Mensing</last_name>
      <phone>339-222-9307</phone>
      <email>gmensing@tuftsmedicalcenter.org</email>
    </contact>
    <investigator>
      <last_name>Raymond Comenzo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Boston University School of Medicine</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02118</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jill MacRae</last_name>
      <phone>617-638-6519</phone>
      <email>jill.macrae@bmc.org</email>
    </contact>
    <investigator>
      <last_name>Vaishali Sanchorawala, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Karmanos Cancer Institute</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christiane Houde</last_name>
      <phone>313-576-9381</phone>
      <email>houdec@karmanos.org</email>
    </contact>
    <investigator>
      <last_name>Jeffrey Zonder, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office</last_name>
      <phone>855-776-0015</phone>
    </contact>
    <investigator>
      <last_name>Morie Gertz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington University in Saint Louis</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Justin King</last_name>
      <phone>314-747-6775</phone>
      <email>jking@dom.wustl.edu</email>
    </contact>
    <investigator>
      <last_name>Keith Stockerl-Goldstein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Newark Beth Israel Medical Center</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Alice Cohen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Columbia University - College of Physicians &amp; Surgeons</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ryan Shelton</last_name>
      <phone>212-304-5485</phone>
      <email>rs3323@cumc.columbia.edu</email>
    </contact>
    <investigator>
      <last_name>Suzanne Lentzsch, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Memorial Sloan-Kettering Cancer Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Winnie Felix</last_name>
      <phone>646-449-1339</phone>
      <email>felixw@mskcc.org</email>
    </contact>
    <investigator>
      <last_name>Heather Landau, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of North Carolina Chapel Hill Comprehensive Cancer Center</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599-1651</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Tita</last_name>
      <phone>984-974-8659</phone>
      <email>elizabeth_tita@med.unc.edu</email>
    </contact>
    <investigator>
      <last_name>Peter Voorhees, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Levine Cancer Institute</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28211</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Asheton Johnson</last_name>
      <phone>980-442-2345</phone>
      <email>asheton.johnson@carolinashealthcare.org</email>
    </contact>
    <investigator>
      <last_name>Manisha Bhutani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roslyn Lewis</last_name>
      <phone>919-688-5579</phone>
      <email>roslyn.lewis@duke.edu</email>
    </contact>
    <investigator>
      <last_name>Sascha Tuchman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Cleveland Clinic - Main Campus</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sherry Fada</last_name>
      <phone>216-445-6235</phone>
      <email>fadas@ccf.org</email>
    </contact>
    <investigator>
      <last_name>Jason Valent, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oregon Health &amp; Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Dreumont</last_name>
      <phone>503-418-2086</phone>
      <email>dreumont@ohsu.edu</email>
    </contact>
    <investigator>
      <last_name>Emma Scott, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cynthia Diaczynsky</last_name>
      <phone>215-662-3173</phone>
      <email>cynthia.diaczynsky@uphs.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>Brendan Weiss, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pittsburg - Hillman Cancer Center</name>
      <address>
        <city>Pittsburg</city>
        <state>Pennsylvania</state>
        <zip>15232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine Tripoli</last_name>
      <phone>412-647-8205</phone>
      <email>tripolica2@upmc.edu</email>
    </contact>
    <investigator>
      <last_name>Alison Sehgal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232-5505</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Piggee</last_name>
      <phone>615-875-6120</phone>
      <email>jessica.piggee@vanderbilt.edu</email>
    </contact>
    <investigator>
      <last_name>Stacey Goodman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas; MD Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Victoria Waterfield</last_name>
      <phone>832-750-1446</phone>
      <email>vwaterfield@mdanderson.org</email>
    </contact>
    <investigator>
      <last_name>Hans Lee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Huntsman Cancer Institute</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aaron Ernst</last_name>
      <phone>801-585-0303</phone>
      <email>tibor.kovacsovics@hci.utah.edu</email>
    </contact>
    <investigator>
      <last_name>Tibor Kovacsovics, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Washington</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heather Rasmussen</last_name>
      <phone>206-288-7140</phone>
      <email>hrasmuss@seattlecca.org</email>
    </contact>
    <investigator>
      <last_name>Edward Libby, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Froedtert &amp; Medical College of Wisconsin, Cancer Center-Froedtert Hospital</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paulette Jacobs</last_name>
      <phone>414-805-4594</phone>
      <email>pjacobs@mcw.edu</email>
    </contact>
    <investigator>
      <last_name>Anita D'Souza, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Eastern Health (Box Hill Hospital)</name>
      <address>
        <city>Box Hill</city>
        <zip>3128</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anthony Schwarer</last_name>
      <phone>(261) 390-9495 X02</phone>
      <email>a.schwarer@alfred.org.au</email>
    </contact>
    <investigator>
      <last_name>Peter Schwarer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Amyloidosis Clinic Cnr Darcy Road and Bridge St. Westmead</name>
      <address>
        <city>Sydney</city>
        <zip>2145</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Fisher</last_name>
      <phone>+61 2 9845 9268</phone>
      <email>lisa.fisher@health.nsw.gov.au</email>
    </contact>
    <investigator>
      <last_name>Fiona Kwok, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The University of Queensland-Princess Alexandra Hospital (PAH)</name>
      <address>
        <city>Wooloongabba</city>
        <zip>4102</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steven Ivanhoe</last_name>
      <phone>+61 7 3176 7154</phone>
      <email>steven.ivanhoe@health.qld.gov.au</email>
    </contact>
    <investigator>
      <last_name>Peter Mollee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitatsklinik fur Innere Medizin 1 Kinische Abteilung fur Onkologie Aligemeines Krankenhaus - Universitatskliniken</name>
      <address>
        <city>Wien</city>
        <zip>A-1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ursula Schaff</last_name>
      <email>ursula.schaeff@meduniwien.ac.at</email>
    </contact>
    <investigator>
      <last_name>Hemine Agis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ZNA Stuivenberg</name>
      <address>
        <city>Antwerpen</city>
        <zip>2060</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caroline De Man</last_name>
      <email>caroline.deman@zna.be</email>
    </contact>
    <investigator>
      <last_name>Ka Lung Wu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ULB Hopital Erasme</name>
      <address>
        <city>Brussel</city>
        <zip>1070</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linda Bartholomees</last_name>
      <phone>3216347588</phone>
      <email>linda.bartholomees@uzleuven.be</email>
    </contact>
    <investigator>
      <last_name>Virginie De Wilde, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UZ Gasthuisberg</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Saskia Cremers</last_name>
      <email>saskia.cremers@uzleuven.be</email>
    </contact>
    <investigator>
      <last_name>Michel Delforge, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Calgary-Southern Alberta Cancer Research Institute</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N 4N2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sajjin Kunhi</last_name>
      <phone>403-521-3046</phone>
      <email>sajjin.kunhi@albertahealthservices.ca</email>
    </contact>
    <investigator>
      <last_name>Victor Zepeda, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cross Cancer Institute</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G 122</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Gursky</last_name>
      <phone>780-989-5970</phone>
      <email>jennifer.gursky@albertahealthservices.ca</email>
    </contact>
    <investigator>
      <last_name>Chris Venner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Princess Margaret Cancer Research Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 1X6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Vishal Kukreti, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jewish General Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3T 1E2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Gyger, MD</last_name>
    </contact>
    <investigator>
      <last_name>Martin Gyger, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Morten Salomo</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital de la Cote de Nacre Avenue</name>
      <address>
        <city>Caen Cedex 9</city>
        <zip>14033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emilie Marin</last_name>
      <phone>+33 2 31 27 20 72</phone>
      <email>marin-e@chu-caen.fr</email>
    </contact>
    <investigator>
      <last_name>Margaret Macro, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Henri Mondor</name>
      <address>
        <city>Creteil</city>
        <zip>94010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ouchra Chafiq</last_name>
      <phone>+33 1 49 81 41 82</phone>
      <email>bouchra.chafiq@hmn.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Karim Belhadj, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Dijon - Hopital du Bocage</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monique Grandjean</last_name>
      <phone>+33 3 80 29 50 47</phone>
      <email>monique.grandjean@chu-dijon.fr</email>
    </contact>
    <investigator>
      <last_name>Denis Caillot, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Dupuytren - CHU Limoges</name>
      <address>
        <city>Limoges</city>
        <zip>87042</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Lavergne</last_name>
      <phone>+33 5 55 05 8637</phone>
      <email>david.lavergne@chu-limoges.fr</email>
    </contact>
    <investigator>
      <last_name>Arnaud Jaccard, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Pitié-Salpêtrière</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raouf Benchikh</last_name>
      <email>raouf.benchikh@psl.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Sylvain Choquet, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopitaux Lyon Sud</name>
      <address>
        <city>Pierre-Benite Cedex</city>
        <zip>69495</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Magali Maire</last_name>
      <phone>+33 4 78 86 43 34</phone>
      <email>magali.maire@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>Lionel Karlin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service d'Hermatologie CHU de Poitiers</name>
      <address>
        <city>Poitiers</city>
        <zip>86000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elodie Rogeon</last_name>
      <phone>+33 5 49 44 46 89</phone>
      <email>elodie.rogeon@chu-poitiers.fr</email>
    </contact>
    <investigator>
      <last_name>Frank Bridoux, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Rennes, Service de Medecine Interne</name>
      <address>
        <city>Rennes Cedex 2</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charlotte Cernon</last_name>
      <phone>+33 2 99 28 98 12</phone>
      <email>charlotte.cernon@chu-rennes.fr</email>
    </contact>
    <investigator>
      <last_name>Olivier Decaux, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Charite-Universitatsmedizin</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anja Ullrich-Noss</last_name>
      <phone>+49 30 450513512</phone>
      <email>anja.ullrich-noss@charite.de</email>
    </contact>
    <investigator>
      <last_name>Axel Nogal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Essen</name>
      <address>
        <city>Essen</city>
        <zip>45122</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christiane Kuhnert</last_name>
      <phone>49 20/723 2553</phone>
      <email>christiane.kuhnert@uk-essen.de</email>
    </contact>
    <investigator>
      <last_name>Alexander Carpinteiro, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitatsklinikum Hamburg-Eppendorf (UKE)</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Petra Kuhne</last_name>
      <phone>049/7410-54851/-55664</phone>
      <email>t.hansen@uke.de</email>
    </contact>
    <investigator>
      <last_name>Timon Hansen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitatsklinikum Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Florian Michel</last_name>
      <phone>+49 6221567805</phone>
      <email>florian.michel@meduni-heldelberg.de</email>
    </contact>
    <investigator>
      <last_name>Stefan Schoenland, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Alexandra General Hospital of Athens</name>
      <address>
        <city>Athens</city>
        <zip>11528</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Efstathios Kastritis, MD</last_name>
      <phone>2103381549</phone>
      <email>ekastritis@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Efstathios Kastritis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital of Patras</name>
      <address>
        <city>Patra</city>
        <zip>26504</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vassiliki Zafeiropoulou</last_name>
      <phone>6944960012</phone>
      <email>vickzafirop@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Anargyros Symeonidis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hadassah University Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <zip>91120</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dorit Cohen</last_name>
      <phone>+972-2-6779267</phone>
      <email>sdorit@hadassah.org.il</email>
    </contact>
    <investigator>
      <last_name>Moshe Gatt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Meir Medical Center</name>
      <address>
        <city>Kfar Saba</city>
        <zip>44281</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neta Shmueli</last_name>
      <phone>972-9-7471709</phone>
    </contact>
    <investigator>
      <last_name>Izhar Hardan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Chaim Sheba Medical Center</name>
      <address>
        <city>Ramat Gan</city>
        <zip>52621</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vared Temam</last_name>
      <phone>972-523491626</phone>
      <email>vared.temam@sheba.health.gov.il</email>
    </contact>
    <investigator>
      <last_name>Merav Leiba, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tel Aviv Sourasky Medical Center</name>
      <address>
        <city>Tel Aviv</city>
        <zip>64239</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Orit Bar-Am</last_name>
      <phone>0520-4266647</phone>
      <email>oritb@tlvmc.gov.il</email>
    </contact>
    <investigator>
      <last_name>Svetlana Trestman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Policlinico S.Orsola Malpighi, Unita' Operativa di Ematologia</name>
      <address>
        <city>Bologna</city>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Federica Pedali</last_name>
      <phone>39 051 2143225</phone>
      <email>federica.pedali@unibo.it</email>
    </contact>
    <investigator>
      <last_name>Michele Cavo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Policlinica San Matteo</name>
      <address>
        <city>Pavia</city>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Carnevale Baraglia</last_name>
      <phone>+39 0382 502967</phone>
      <email>anna.carnevalebaraglia@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Giampaolo Merlini, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Sant'Andrea, U.O.S.</name>
      <address>
        <city>Rome</city>
        <zip>00189</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giacinto La Verde, MD</last_name>
    </contact>
    <investigator>
      <last_name>Giacinto La Verde, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Medical Center Groningen</name>
      <address>
        <city>Groningen</city>
        <zip>9713 GZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bouke Hazenberg, MD</last_name>
      <phone>+31 50 361 3432</phone>
      <email>b.p.c.hazenberg@umcg.nl</email>
    </contact>
    <investigator>
      <last_name>Bouke Hazenberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitair Medisch Centrum Utrecht</name>
      <address>
        <city>Utrecht</city>
        <zip>3584 CX</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monique Minnema, MD</last_name>
      <phone>+31 88 755 7230</phone>
      <email>hematologie@umcutrecht.nl</email>
    </contact>
    <investigator>
      <last_name>Monique Minnema, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MTZ Clinical Research Sp. z o.o.</name>
      <address>
        <city>Warszawa</city>
        <zip>02-106</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wieslaw Jedrzejczak, MD</last_name>
      <phone>+48 (0) 22-599-28-18</phone>
      <email>wiktor@amwar.edu.pl</email>
    </contact>
    <investigator>
      <last_name>Wieslaw Jedrzejczak, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clínica Universidad de Navarra</name>
      <address>
        <city>Pamplona</city>
        <state>Nevarra</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jesús Fernando San Miguel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari Germans Trias i Pujol</name>
      <address>
        <city>Badalona</city>
        <zip>08916</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Albert Oriol, MD</last_name>
      <phone>34934978987-3546</phone>
      <email>aoriol@iconcologia.net</email>
    </contact>
    <investigator>
      <last_name>Albert Oriol, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic de Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joan Blade, MD</last_name>
      <phone>34-93-2275400</phone>
      <email>jblade@clinic.ub.es</email>
    </contact>
    <investigator>
      <last_name>Joan Blade, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario 12 de Octubre</name>
      <address>
        <city>Madrid</city>
        <zip>28041</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabel Merino</last_name>
      <phone>34-91 3908652</phone>
      <email>imerino@h12o.es</email>
    </contact>
    <investigator>
      <last_name>Joaquin Martinez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Puerta de Hierro - Maiadahonda</name>
      <address>
        <city>Madrid</city>
        <zip>28222</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabel Krsnik, MD</last_name>
      <phone>34911917913</phone>
      <email>isabel.krsnik@salud.madrid.org</email>
    </contact>
    <investigator>
      <last_name>Isabel Krsnik, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospitals Birmingham NHS Foundation Trust - Queen Elizabeth Hospital</name>
      <address>
        <city>Birmingham</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Biruk Asfaw</last_name>
      <phone>44 (0) 121 371 4398</phone>
      <email>biruk.asfaw@uhb.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Mark Cook, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospitals Bristol NHS Foundation Trust - Bristol Haematology and Oncology Centre</name>
      <address>
        <city>Bristol</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anja Schmidtmann</last_name>
      <phone>+44 (0) 117 34 26743</phone>
      <email>anja.schmidtmann@uhbristol.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>James Griffin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Leicester Royal Infirmary</name>
      <address>
        <city>Leicester</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kas Siguake</last_name>
      <phone>+44 116 258 5899</phone>
      <email>kas.sihuake@uhl-tr.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Mamta Garg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Royal Free London NHS Foundation Trust-The Royal Free Hospital</name>
      <address>
        <city>London</city>
        <zip>NW3 2PF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashutosh Wechalekar, MD</last_name>
      <phone>44 2074332758</phone>
      <email>a.wechalekar@ucl.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Ashutosh Wechalekar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NNUH NHS Foundation Trust - Norfolk and Norwich University Hospital</name>
      <address>
        <city>Norwich</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Helen Darby</last_name>
      <phone>+44 (0)1603 289 875</phone>
      <email>helen.darby@nnuh.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Martin Auger, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Southampton General Hospital</name>
      <address>
        <city>Southampton</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew Jenner</last_name>
      <phone>0044023 8120 4438</phone>
      <email>Matthew.Jenner@uhs.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Matthew Jenner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Canada</country>
    <country>Denmark</country>
    <country>France</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Poland</country>
    <country>Spain</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <lastchanged_date>November 9, 2016</lastchanged_date>
  <firstreceived_date>December 2, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Amyloidosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
